Early postmenopausal bone loss is prevented by estrogen and partially by 1α-OH-vitamin D3: Therapeutic effects of estrogen and/or 1α-OH-vitamin D3

Calcified Tissue International

Volumn 65, Issue 1, 1999, Pages 16-22

  Gorai, I ^a   Chaki, O ^a   Taguchi, Y ^a   Nakayama, M ^a   Osada, H ^b   Suzuki, N ^c   Katagiri, N ^d   Misu, Y ^a   Minaguchi, H ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Saiseikai Yokohama City Nanbu Hospital   (Japan)

^d Yokohama Minami Kyosai Hospital   (Japan)

Author keywords

1 (OH)D3; Early postmenopause; Estrogen; Femoral neck BMD; Lumbar spine BMD

Indexed keywords

ALBUMIN; ALFACALCIDOL; ALKALINE PHOSPHATASE; CALCIUM; CONJUGATED ESTROGEN; CREATININE; ESTROGEN; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE RADIOGRAPHY;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; CALCIUM; DRUG THERAPY, COMBINATION; ESTROGENS, CONJUGATED (USP); FEMALE; FEMUR NECK; HUMANS; HYDROXYCHOLECALCIFEROLS; HYDROXYPROLINE; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; PHOSPHORUS;

EID: 0032975067     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900651     Document Type: Article

References (28)

1. Prince RI (1994) Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. Endocrinol Rev 15:301-309
2. Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnston CC (1986) The influence of age on bone mineral regulating hormones. Bone 7:421-425
3. Hartwell D, Riis BJ, Christiansen C (1990) Changes in vitamin D metabolism during natural and medical menopause. J Clin Endocrinol Metab 71:127-132
4. Falch JA, Oftebro H, Haug E (1987) Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein. J Clin Endocrinol Metab 64:836-841
5. 3 in oophorectomized women. J Clin Endocinol Metab 71:1288-1293
6. Prince RL, Dick I, Garcia-Webb P, Retallack RW (1990) The effects of the menopause on calcitriol and parathyroid hormone: responses to a low dietary calcium stress test. J Clin Endocrinol Metab 70:1119-1123
7. 3. J Clin Endocrinol Metab 70:1055-1061
8. Villareal DT, Civitelli R, Chines A, Avioli LV (1991) Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 72:628-634
9. Tsai KS, Heath H III, Kumar R, Riggs BL (1984) Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest 73:1668-1672
10. Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD (1982) Vitamin D and bone health in the elderly. Am J Clin Nutr 36:1014-1031
11. Joborn C, Ljunghall S, Larsson K, Lindh B, Naessen T, Wide L, Akerstrom G, Rastad J (1991) Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement. Clin Endocrinol (Oxf) 34: 335-339
12. Cosman F, Shen V, Xie F, Seibel M, Ratcliffe A, Lindsay R (1993) Estrogen protection against bone-resorbing effects of parathyroid hormone infusion. Ann Intern Med 118:337-343
13. Fukayama S, Tashjian AH (1989) Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 124:397-401
14. Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-1, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833
15. Price PA, Nishimoto S (1980) Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 77:2234-2239
16. Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E (1975) Metabolism of immunoreactive parathyroid hormone in the dog. J Clin Invest 56:39-48
17. 3. Bone Miner 3:47-52
18. 3. Bone Miner 20:223-234
19. Caniggia A, Nuti R, Lore F, Martini G, Fredian B, Giovani S (1993) Total body absorptiometry in postmenopausal osteoporosis patients treated with 1 alpha-hydroxylated vitamin D metabolites. Osteoporosis Int (suppl)1:S181-S185
20. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370-376
21. 3: a three-year prospective study. Clin Rheumatol 11:1492-1497
22. 3. Osteoporosis Int (suppl) 1:S176-S180
23. Riggs BL, Nelson KI (1985) Effect of long-term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis. J Clin Endocrinol Metab 61: 457-461
24. Lukert B, Higgins J, Stoskopf M (1992) Menopausal bone loss is partially regulated by dietary intake of vitamin D. Calcif Tissue Int 51:173-179
25. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Int Med 115:505-512
26. 3: a prospective, controlled, randomized study. J Clin Endocrinol Metab 82:2476-2482
27. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T (1997) Expression of estrogen receptor β in rat bone. Endocrinology 138:4509-4517
28. Civitelli R (1995) The role of vitamin D metabolites in the treatment of osteoporosis. Calcif Tissue Int 57:409-414